Stimulation of innate immune cells Induced by probiotics: participation of toll- like receptors by Maldonado Galdeano, María Carolina et al.
Stimulation of Innate Immune Cells Induced by Probiotics: Participation of Toll-
Like Receptors
Maldonado Galdeano C1,2, Lemme-Dumit JM2, Thieblemont N3-6, Carmuega E7, Weill R8 and Perdigón G1,2*
1Laboratorio de Inmunología, Centro de Referencia para Lactobacilos (CERELA-CONICET), Tucumán, Argentina
2Cátedra de Inmunología, Instituto de Microbiología, Facultad de Bioquímica, Química y Farmacia, Universidad Nacional de Tucumán, Argentina
3INSERM U1016 Cochin Institute, Paris, France
4CNRS UMR 8104, Paris, France
5Université Paris Descartes, France
6Center of Excellence, LABEX, France
7CESNI (Centro de Estudios Sobre Nutrición Infantil), Buenos Aires, Argentina
8Científico LATAM, DANONE Argentina SA, Buenos Aires, Argentina
*Corresponding author: Perdigón G, Centro de Referencia para Lactobacilos (CERELA-CONICET), Chacabuco 145 (T4000ILC), Tucumán, Argentina, Tel: 54 381
4310465, Fax: 54 381 4005600; E-mail: perdigon@cerela.org.ar
Received date: November 07, 2014, Accepted date: January 13, 2015, Published date: January 20, 2015
Copyright: © 2015 Maldonado GC, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Objective: The present work aimed to study the functionality of macrophages from different locations
(peritoneum, spleen and Peyer´s patches) when they were stimulated with probiotics microorganisms: Lactobacillus
casei CRL 431 and Lactobacillus paracasei CNCM I-1518 or a Probiotic Fermented Milk (PFM) through Toll-Like
Receptors (TLRs), prior challenged with agonists or antagonists of TLRs.
Methods: BALB/c mice received in the drinking water, the probiotic bacteria (L. casei CRL 431 and L. paracasei
CNCM I-1518) or the PFM. We focused our investigation mainly on the phagocytic activity of macrophages from
peritoneum, spleen and Peyer’s patches and cytokine production were evaluated prior challenged with TLR2 and
TLR4 agonists or antagonists. The microbicidal activity of macrophages and against an infection with Salmonella
typhimurium was also studied. To assess the role of TLR in probiotic stimulation, we evaluated the phagocytic
activity, cytokine production and Immunoglobin G (IgG) anti-OVA in C57BL/6 knockout mice to MyD88, TLR2 and
TLR4.
Results: In BALB/c mice, the best effect in the phagocytosis assay was obtained with the probiotic bacteria L.
casei CRL 431, this effect was reinforced with TLR2 agonist. The production of different cytokines (IL-10 and IL-6)
was improved with the probiotic treatments and this production was ameliorated with TLRs agonists. The
antimicrobial activity was increased with L. casei CRL 431 and L. paracasei CNCM I-1518, TLR2 and TLR4
antagonists had a negative effect on microbicidal activity. The administration of probiotic bacteria or PFM improved
the host response against S. typhimurium controlling the infection during the first hours post-infection. In C57BL/6
knockout mice, phagocytic activity was significantly diminished in comparison to wild type mice and the probiotic
bacteria or PFM administration was not able to improve this activity. The IL-10 production was increased at a
concentration of 108 cells/ml of L. casei CRL 431 in TLR2-/- and TLR4-/-, but not in MyD88-/- mice. The administration
of probiotic bacteria or PFM did not play a stimulating effect in the systemic immune response against to OVA
antigen in knockout mice.
Conclusions: Probiotics modulate the different signaling pathways of innate immune cells through the TLRs. The
macrophages activation depends on location of them and that different probiotic strains of Lactobacilli can evoke
different intensity of responses. The data suggest that probiotic not only promote a major expression of TLRs but
also use these receptors via the innate immune cells as macrophages to stimulate and modulate the immune
response.
Keywords: Mucosal immunity; Probiotics; Macrophages; Toll-Like
Receptors; Gut signalling; Phagocytosis; Microbicidal activity
Introduction
Innate immune cells are often described as the ‘sentinel of the
immune system’ because they are among the first cell types to react in
the host, against pathogens, tumor, or differents injuries [1].
The cells that play a critical role in initiating the innate immune
response are the macrophages and dendritic cells [2]. Macrophages are
resident phagocytic cells in lymphoid and non-lymphoid tissues and
they are involved in steady-state tissue homeostasis, via the clearance
of apoptotic cells and immunity [3-5]. Tissue-resident macrophages
are best known for their role as immune sentinels in the frontline of
tissue defense where they are discretely positioned and
transcriptionally programmed for the encounter with pathogens or
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environmental challenges [4]. The phenotype of resident macrophages
in tissues is determined by the tissue microenvironment, the
extracellular matrix, secretory products and surface molecules of
neighboring cells.
Macrophages express a wide array of Pattern Recognition Receptors
(PRR) to recognize and respond to Microbe-Associated Molecular
Patterns (MAMPs). This recognition induces a signaling cascade that
can result in the production of cytokines, chemokines, and other
effector molecules activating the innate immune response in the host
[6]. The Toll-Like Receptors (TLRs) family, which is the best PRR
characterized, includes TLR1, 2, 4, 5, 6 and 11 recognize mainly
microbial membrane components and are expressed on the cell
surface, and TLR3, 7, 8 and 9 that recognize nucleic acids of bacterial
or viral origin, are expressed in intracellular compartments [7].
Lactobacilli are able to modulate immune response of the host by
interaction with the immune cells and the intestinal epithelium. There
are many evidence concerning to the role of probiotics, especially for
Lactic Acid Bacteria (LAB), in the maintenance of health or in the
prevention of disease [8]. Probiotics are defined as “live
microorganisms which, when administered in adequate amounts
confer a health benefit to the host” [9]. Studies have shown that
different strains of Lactobacilli can evoke different responses in the
host [10], therefore the results from one strain cannot be generalized
to others.
The aim of this work was to study by in vitro and ex vivo assays, the
participation of TLRs in macrophages when they are stimulated by
different probiotics bacteria or Probiotic Fermented Milk. The effect
from macrophages of Peyer’s patches and in distant sites from
intestine such as peritoneum and spleen were studied. We focused on
the role of TLR2 and 4, present in the surface of macrophages, that are
involved in innate immunity and the way by which the oral
administration of probiotics bacteria or Probiotic Fermented Milk
through of these TLR mediate activation of these cells measuring the
phagocytic and microbicidal activity. The previous studies were
confirmed using knockout mice to MyD88-/-, TLR2-/- and TLR4-/-. We
also analyzed by in vivo assays the antimicrobicidal activity against an
intraperitoneal infection with Salmonella typhimurium prior
stimulation with probiotic bacteria or Probiotic Fermented Milk.
Methods
Mice
BALB/c mice weighing 25 to 30 g (6 weeks of age) were obtained
from the inbred colony maintained at Institute of Microbiology of
Facultad de Bioquímica, Química y Farmacia de la Universidad
Nacional de Tucumán. The animals were fed on balanced rodent food
and water ad libitum. Wild-type (WT) C57BL/6 mice were purchased
from Janvier (France). MyD88-/-, TLR4-/- and TLR2-/- mice were
kindly provided by Dr. S. Akira, Japan, crossed in the C57BL/6
background and bred in the animal facilities at the Hôpital Necker of
Paris, France, under specific pathogen-free conditions. All
experiments have been conducted in accordance with the European
Union Council Directives (86/609/EEC) and with the institutional
guidelines (INSERM: Institut National de la Santé et de la Recherche
Médicale). The animal facility is accredited by an agreement delivered
by the Prefecture de Police of Paris, France and for the guidelines from
Universidad Nacional de Tucumán, Argentina.
Bacterial Strains and Culture Conditions
Lactobacillus casei CRL 431 and Lactobacillus paracasei CNCM
I-1518 were obtained from the CERELA culture collection (San Miguel
de Tucumán, Argentina). The Samonella enterica serovar
typhimurium (S. typhimurium) used in this study was obtained from
the Bacteriology Department of the Hospital del Niño Jesús (San
Miguel de Tucumán, Argentina). L. casei and L. paracasei were
cultured in a sterile Man, Ragosa and Sharpe (MRS) broth (Britania,
Buenos Aires, Argentina) and S. typhimurium was cultured in a sterile
Brain Heart Infusion (BHI) broth (Britania, Buenos Aires, Argentina).
Probiotic Fermented Milk (PFM)
Commercial Probiotic Fermented Milk (PFM) containing as
starters Lactobacillus delbrueckii subsp. bulgaricus (108 CFU/ml) and
Streptococcus thermophilus (108 CFU/ml) and probiotic strain
Lactobacillus paracasei CNCM I-1518 (108 CFU/ml) was used.
L. casei and Probiotic Fermented Milk Administration
For ex vivo assays, the mice were housed in individual boxes of
three mice each one and given a viable Lactobacilli suspension in the
drinking water, L. casei CRL 431 was administered for 7 consecutive
days and L. paracasei CNCM I-1518 or Probiotic Fermented Milk
(PFM) for 5 consecutive days, due to these time were the optimal
period of administration for the probiotic bacteria and PFM to activate
the intestinal immune system in healthy animals, previously
determined in our laboratory [8,11]. The bacterial suspensions were
prepared from overnight cultures grown at 37°C in 5 ml of MRS broth.
The cells were harvested by centrifugation at 5,000 g for 10 min,
washed three times with fresh Phosphate Saline Solution (PBS) and
then re-suspended in 5 ml of sterile 10% (wt/vol) local commercial
skim milk powder (Svelty Figura, Nestlé, Argentina). The bacterial
suspensions were diluted 1:30 in water and administered ad libitum to
the mice. The final concentration of probiotic bacteria was 2 ± 1×108
CFU/ml. The PFM was also administered ad libitum to the mice.
Ex Vivo Phagocytosis Assay of Peritoneal, Spleen and Peyer’s
Patches Macrophages
Peritoneal, spleen and Peyer’s patches macrophages from BALB/c
mice treated with probiotic bacteria or PFM, were obtained according
to a previously described method in our laboratory [12,13], and the
concentration was adjusted at 1×106 cells/ml. The macrophages were
stimulated with 20 µl Pam3CSK4 (1 µg/ml) (Synthetic triacylated
lipoprotein-TLR1/2 ligand - InvivoGen, San Diego, CA, USA), MAb
mTLR2 (10 µg/ml) (Purified monoclonal antibody to mouse TLR2 -
InvivoGen), LPS-EB Ultrapure (10 µg/ml) (Ultrapure
lipopolysaccharide from E. coli 0111:B4 strain-TLR4 ligand -
InvivoGen) and LPS-RS Ultrapure (10 µg/ml) (Ultrapure
lipopolysaccharide from Rhodobacter sphaeroides -TLR4 antagonist –
InvivoGen) (2 h; 37°C; 5% CO2).
Phagocytosis assay was performed using a Saccharomyces cerevisiae
suspension at a concentration of 107 cells/ml. Opsonized yeast in
mouse autologous serum (10%) were added to 200 µl of macrophage
suspension. The mixture was incubated for 30 min at 37°C. The
percentage of phagocytosis was expressed as the percentage of
phagocyting macrophages in 100 cells counted in an optical
microscope.
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In Vitro Assays for Cytokine Determination
The cytokines IL-6 and IL-10 production by peritoneal, spleen and
Peyer´s patches macrophages were determined by in vitro assay.
Peritoneal, spleen and Peyer’s patches macrophages from untreated
BALB/c mice were isolated on RPMI-1640 medium (Sigma, St. Louis,
Mo) and adherent in TC-Plates (6 wells, sterile with LID Cellstar
Greiner bio-one) (1 h; 37°C; 5% CO2) and the final concentration was
adjusted at 1×106 cells/ml/wells. TLR2 and TLR4 agonist and
antagonist 20 µl (1, 10 or 10, 10 µg/ml, respectively) (InvivoGen, San
Diego, CA, USA) were added to the cells cultures (2 h; 37°C; 5% CO2).
Overnight cultures of L. casei CRL 431 and L. paracasei CNCM I-1518
were centrifuged (5,000 rpm; 10 min), washed three times with PBS
sterile, and 20 µl was added to the macrophages culture to final
concentrations of 108 CFU/ml and 20 µl of PFM was added directly to
the culture. They were incubated (12 h; 37°C; 5% CO2). The
supernatants of culture media were recovered for cytokine
determination by ELISA test according the manufacturer's instructions
(BD OptEIA BD bioscience, San Diego, USA).
Ex Vivo Microbicidal Activity of Peritoneal and Spleen
Macrophages
After 7 days of administration of L. casei CRL 431 and 5 days of
administration of L. paracasei CNCM I-1518 and PFM respectively,
the peritoneal and spleen macrophages from BALB/c mice were
cultured in RPMI-1640 medium (Sigma, St. Louis, Mo) and incubated
in TC-Plates (6 wells, sterile with LID Cellstar Greiner bio-one) (1 h;
37°C; 5% CO2), the final concentration was adjusted at 1×106 cells/ml/
wells. The macrophages were incubated with 20 µl of TLR2 or TLR4
antagonists (10 and 10 µg/ml, respectively) (InvivoGen, San Diego,
CA, USA) (2 h; 37°C; 5% CO2) and then were infected with 1 ml of
1×107 CFU of S. typhimurium. The bacterium/macrophage ratio was
10:1. After 30 min of incubation at 37°C, extracellular bacteria were
gently removed by washing with PBS and then RPMI medium
containing 100 μg/ml of gentamicin was added and incubated for 60
min. Finally, the cells were lysed with 1 ml of Triton X-100 1% in
RPMI. Serial dilutions of the suspension of cells lysed were plated on
SS agar (Salmonella - Shigella agar, Britania, Buenos Aires Argentina).
The counting forming units (CFU) of S. typhimurium were
determinate after incubation for 24 h at 37°C.
In Vivo Challenge with Salmonella typhimurium
BALB/c mice were fed with L. casei CRL 431 (7 consecutive days),
L. paracasei CNCM I-1518 (5 consecutive days) or PFM (5 consecutive
days). After that, mice were infected intraperitoneally with 100 µl of a
suspension of Salmonella typhimurium (106 CFU/ml). The mice were
sacrificed by cervical dislocation. The animal protocols were according
to the Guide for the Care and Use of Laboratory Animals – National
Research Council, 1996. All animal protocols were pre-approved by
the Ethical Committee of Universidad Nacional de Tucumán and all
experiments comply with the current laws of Argentina. Liver and
spleen were aseptically removed and placed into sterile tubes
containing 5 ml of peptone water (0.1%). The samples were
immediately homogenized and serial dilutions were made and spread
onto the surface of SS agar (Salmonella – Shigella agar, Britania,
Buenos Aires, Argentina). The counting of bacterial cells in spleen and
liver were checked in the following post-infection time intervals: 18,
24, 30, 48 and 72 hours.
Ex Vivo Phagocytosis Assay of Peritoneal Macrophages in
Knockout Mice
C57BL/6 mice six-weeks-old were divided into 4 groups: wild type,
MyD88-/-, TLR4-/- and TLR2-/- group. Each group was divided into 3
subgroups according to the dietary supplement: water, L. casei CRL
431 suspension for 7 days, or PFM for 5 days. At the end of the feeding
period, the animals were sacrificed. Peritoneal macrophages, were
isolated and the concentration were adjusted at 1×106 cells/ml.
Phagocytosis assay was performed using a Saccharomyces cerevisiae
suspension at a concentration of 1×107 cells/ml as was previously
described.
IL-10 Production by Peritoneal Macrophages from Knockout
Mice
Peritoneal macrophages from untreated wild type, MyD88-/-,
TLR4-/- and TLR2-/- C57BL/6 mice were isolated on RPMI-1640
medium (Sigma-Aldrich, St. Louis, Mo, USA) supplemented with
antibiotics and 10% fetal calf serum (Invitrogen, Cergy-Pontoise,
France). A volume of 500 µl (1×106 cells/ml) was plated per well into
24-wells plates. Macrophages were then cultured with different
concentrations (109, 5×108, 108, 5×107, 107, 5×106, 106 and 5×105) of
the probiotic bacterium L. casei CRL 431 for 24 hrs at 37°C. Culture
supernatants were harvested and stored at -80°C until cytokines were
measured by ELISA test according the manufacturer's instructions
(R&D systems, Lille, France).
Detection of Anti OVA IgG in Serum
A wild type and three knockout mice (MyD88-/-, TLR4-/- and
TLR2-/- C57BL/6) were used in this study. For each class of mouse,
three groups were used according to the dietary supplement: water, L.
casei CRL 431 suspension for 7 days or PFM for 5 days.
At the end of the feeding period, all the animals were injected
subcutaneously with 100 µl three times every 48 hours with 15 µg of
chicken egg albumin (OVA) (Sigma-Aldrich, St. Louis, Mo, USA) in
PBS plus adjuvant complete Freund (Difco Laboratories, Detroit,
Michigan, USA) (1:1). The serum samples were collected 20 days after
of the immunization and storage at -80°C until specific anti OVA IgG
determination by ELISA test according the manufacturer's instructions
(R&D systems, Lille, France).
Statistics
For all the studies, each group assayed was of 3 mice. The results are
showed as the means of three independent trials with their respective
SEM (standard error of the mean) from 9 mice. Statistical analysis was
performed using MINITAB 15 software (Minitab, Inc.) by ANOVA
general linear model followed by Tukey’s post hoc test, and P≤0.05
was considered significant.
Results
Probiotic Effect on the Phagocytic Activity of Macrophages:
Implication of TLRs
To evaluate the role of TLRs in macrophages activation, we
determined the percentage of phagocitosis. Peritoneal macrophages
activity was increased significantly after L. casei CRL 431 and PFM
stimulation respect to the untreated group and it also showed an
Citation: Maldonado Galdeano C, Lemme-Dumit JM, Thieblemont N, Carmuega E, Weill R, et al. (2015) Stimulation of Innate Immune Cells
Induced by Probiotics: Participation of Toll-Like Receptors. J Clin Cell Immunol 6: 283. doi:10.4172/2155-9899.1000283
Page 3 of 9
J Clin Cell Immunol
ISSN:2155-9899 JCCI, an open access journal Volume 6 • Issue 1 • 1000283
increase when the cells were previously confronted with TLR2 agonist.
The same behavior was obtained when antagonized the TLR2, where
the phagocytic activity was increased only in macrophages from mice
that were treated with L. casei CRL 431. However, the phagocytic
activity decreased when the macrophages were faced to TLR4 agonist
or antagonist respect to the control group and this activity does not
improve in the cells that were previously stimulated with L. casei CRL
431 or PFM (Figure 1A).
Figure 1: Phagocytic activity of macrophages isolated from
peritoneum, Peyer’s patches and spleen. Effects of TLR2 and TLR4
agonist and antagonist on phagocytic activity of macrophages from
BALB/c mice stimulated previously with Lactobacillus casei CRL
431, 7 consecutive days of administration and probiotic fermented
milk, 5 consecutive days of administration. (A) Peritoneal
macrophages. (B) Peyer’s patches macrophages. (C) Spleen
macrophages. a,b,c,dMeans values for peritoneum, Peyer’s patches
and spleen macrophages without a common letter differ
significantly (P<0.05). The error bars indicate standard deviations
for 3 independent determinations per mouse.
The assay performed on Peyer’s patches showed a significant
increase of the activity of macrophages stimulated with PFM
compared to untreated group. There was an increased in the
phagocytic activity in those macrophages stimulated with L. casei CRL
431 and then confronted with TLR2 and TLR4 agonists and
antagonists, respect to the controls group. Regard to PFM, the
phagocytic activity was increased only when the macrophages were
faced to TLR4 agonist, compared with the control (Figure 1B).
The analysis of the phagocytic activity on spleen macrophages
showed that both L. casei CRL 431 and the PFM supplementation
induced significant increases in this activity compared to the untreated
group. Stimulation with probiotic bacteria and then confronted with
TLR2 agonist or antagonist showed slight increase compared to their
control group, whereas stimulation with PFM showed a decrease in
the phagocytic activity. On the other hand, stimulation with TLR4
agonist or antagonist showed a decrease in the activity compared to
their control group (Figure 1C).
IL-10 and IL-6 Determination
The profile of IL-10 production by peritoneal macrophages showed
a significant increase when these cells were stimulated with L. casei
CRL 431 or PFM compared to untreated control, and the same pattern
were obtained with TLRs agonists and antagonists. Whereas, the
stimulation with L. paracasei CNCM I-1518 showed not significant
increase (Figure 2A).
The IL-10 production from Peyer’s patches showed a significant
decrease when the macrophages were stimulated with L. casei CRL
431, L. paracasei CNCM I-1518 or PFM compared to the untreated
control. We observed similar values to the untreated control, when the
macrophages were confronted with TLR2 agonist for L. casei CRL 431,
while there was an increase of IL-10 production from macrophages
faced to TLR2 and TLR4 antagonists when the macrophages were
stimulated with L. paracasei CNCM I-1518 compared to their
respective controls. As regard to PFM, IL-10 production was increased
only when the macrophages were faced previously to TLR4 agonist
(Figure 2B).
Spleen macrophages showed a significant increase of IL-10
production when the cells were stimulated with L. casei CRL 431 or L.
paracasei CNCM I-1518 compared to the untreated control, while the
stimulated with PFM, showed similar result to the control. When the
macrophages were stimulated with probiotic bacteria and confronted
with TLRs agonists, there was an increased release of IL-10 compared
to their respective control group, while stimulation with PFM, only
showed increases when was faced to TLR4 agonist. For to TLR4
antagonist we did not observed differences respect the control group
(Figure 2C).
The IL-6 productions by peritoneal macrophages showed that this
cytokine was not increased in macrophages stimulated with probiotic
bacteria and PFM compared to untreated control. Generally, there was
an increased production of the IL-6 when the macrophages were
stimulated with L. casei CRL 431 or L. paracasei CNCM I-1518
previous showdown with TLRs agonists or antagonists respect to the
control, whereas PFM showed an increase when macrophages were
faced to TLR2 agonist and TLR4 antagonist, compared to the control
groups (Figure 2D).
Peyer’s patches macrophages showed an increased level of IL-6
production when these cells were stimulated with L. casei CRL 431, L.
paracasei CNCM I-1518 or PFM compared to the untreated control.
When the macrophages were stimulated with probiotic bacteria or
PFM in addition to TLRs agonist, the cytokine production showed
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significant increases compared to the control groups. On the other
hand, when the macrophages were confronted with TLRs antagonist
the probiotic bacteria or PFM, showed a decrease in the IL-6
production compared to the control groups (Figure 2E).
Figure 2: Effects of TLR2 and TLR4 agonists and antagonists on
cytokines production. In vitro effects of 20 µl at different
concentrations, 1 µg/ml (TLR2 agonist), 10 µg/ml (TLR2
antagonist), 10 µg/ml (TLR4 agonist) and 10 µg/ml (TLR4
antagonist), after added L. casei CRL 431 (grey bar), L. paracasei
CNCM I-1518 (dark-grey bar) and probiotic fermented milk (light-
grey bar), on the production of IL-10 and IL-6 by macrophages
from BALB/c mice; macrophages unstimulated (black bar). (A-D)
Peritoneal macrophages. (B-E) Peyer’s patches macrophages. (C-F)
Spleen macrophages. a,b,c,dMeans values for peritoneum, Peyer’s
patches and spleen macrophages without a common letter differ
significantly (P<0.05). The error bars indicate standard deviations.
The IL-6 production in spleen macrophages showed a significant
increase when the cells were stimulated with probiotic bacteria L. casei
CRL 431 and mainly with L. paracasei CNCM I-1518 compared to the
untreated control, being these increases more significant for the TLRs
agonists. This cytokine also showed an increase when the macrophages
were stimulated with L. casei CRL 431 or L. paracasei CNCM I-1518
for TLRs antagonist; however these values were lower than those
obtained with the TLR agonist (Figure 2F).
Ex Vivo Assays of Microbicidal Activity of Peritoneals and
Spleen Macrophages
The microbicidal activity of peritoneal macrophages decreased
when the TLRs antagonist were added to the cells culture. When the
animals were fed with a L. casei CRL 431 or PFM, the microbicidal
activity increased compared to the untreated control (P<0.05). When
the animals were fed with L. casei CRL 431 or PFM and challenged
with antagonists of TLRs, an increased microbicidal activity was
showed, in comparison to the untreated control group. L. paracasei
CNCM I-1518 showed an increase in microbicidal activity when the
cells were facing to TLR4 antagonist (Figure 3A).
Figure 3: Effects of TLR2 and TLR4 antagonists on microbicidal
activity from BALB/c mice. Ex vivo effects of macrophages
untreated (black bar) and stimulated with L. casei CRL 431 (grey
bar), L. paracasei CNCMI-1518 (dark-grey bar) and probiotic
fermented milk (light-grey bar) and them facing with TLRs
antagonist. (A) Peritoneal macrophages. (B) Spleen macrophages.
a,b,c,dMeans values for peritoneum and spleen macrophages without
a common letter differ significantly (P<0.05). The error bars
indicate standard deviations for 3 independent determinations per
mouse.
Spleen macrophages showed that animals stimulated with L. casei
CRL 431 had higher antimicrobial activity than the untreated control
(P<0.05), but when the cells were blocked with the TLRs antagonist,
this activity decreased compared to the control group. In the case of
animals treated with L. paracasei CNCM I-1518 a slight increase of the
microbicidal activity was shown compared to normal control but
when the cells were antagonized for TLRs, macrophages showed an
increase in the microbicidal activity compared to control group. The
PFM showed less microbicidal activity than the untreated animals, but
this activity increased when cells were antagonized for TLR2 and
TLR4, respectively (Figure 3B).
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In Vivo Antimicrobial Activity Induced by Probiotic Against
an Intraperitoneal Infection with S. typhimurium
We analyzed if the macrophages activity induced by treatment with
probiotic bacteria or PFM was effective against an intraperitoneal
infection with Salmonella typhimurium.
We observed in both liver and spleen tissues that treatment with the
probiotics assayed and the PFM controlled the bacterial counts of S.
typhimurium during the first 24 to 30 hours, after the infection, then
they could not control the infection and the CFU values were similar
to the untreated infection animals, with an increased translocation of
S. typhimurium to the liver and spleen (Figures 4A, 4B).
Figure 4: Effects of intraperitoneal infection. In vivo effects of
BALB/c mice stimulated with L. casei CRL 431 (○) and L. paracasei
CNCM I-1518 ( ) by 7 consecutive days of administration and
probiotic fermented milk ( ) by 5 consecutive days of
administration and intraperitoneal infection control (). Colony
counts are expressed as log10 numbers of bacteria per milliliters of
homogenized. (A) CFU/ml Spleen. (B) CFU/ml Liver. The error
bars indicate standard deviations for 3 independent determinations
per mouse.
Validation of the Previous Results Studies in Knockout Mice
Ex Vivo phagocytosis assay: The results obtained with the wild type
C57BL/6 mice showed that the PFM administration induced
significant increases in the phagocytic activity of peritoneal
macrophages compared to the normal control wild type mice. In
knockout animals (MyD88-/-, TLR4-/- and TLR2-/- C57BL/6), the
ability to phagocytose yeast was decreased to about half of the value
comparatively to the wild type mice. The probiotic bacterium L. casei
CRL 431 or the PFM administration had no effect on the activity of the
peritoneal macrophages (Figure 5).
IL-10 Production from Peritoneal Macrophages Stimulated
with L. Casei CRL 431
In vitro activation of the peritoneal macrophages showed that high
and low concentrations of the probiotic bacteria were not able to
induce IL-10 production. However, L. casei CRL 431 at a
concentration of 108 cells/ml showed a significant production of IL-10
even in knockout TLR2 and TLR4 animals. However deficiency of
MyD88 was decisive for the production of this cytokine from
peritoneal macrophages (Figure 6).
Figure 5: Phagocytic activity of peritoneal macrophages from
knockout mice. Phagocytic activity of macrophages from wild type
C57BL/6 (black bar), TLR2 -/- C57BL/6 (grey bar), TLR4-/- C57BL/6
(dark-grey bar), and MyD88-/- C57BL/6 (light-grey bar) mice
stimulated previously with Lactobacillus casei CRL 431 by 7
consecutive days of administration and probiotic fermented milk, 5
consecutive days of administration. a,b,c,dMeans values for
peritoneal macrophages without a common letter differ
significantly (P<0.05). The error bars indicate standard deviations
for 3 independent determinations per mouse.
Figure 6: IL-10 production of peritoneal macrophages from
knockout mice. Effects of different concentrations of L. casei CRL
431 on the production of IL-10 of peritoneal macrophages from
wild type C57BL/6 (black bar), TLR2 -/- C57BL/6 (grey bar),
TLR4-/- C57BL/6 (dark-grey bar), and MyD88-/- C57BL/6 (light-
grey bar) mice. a,b,c,dMeans values for peritoneal macrophages
without a common letter differ significantly (P<0.05). The error
bars indicate standard deviations.
Influence of Probiotics on the Systemic Immune Response
For the evaluation of the systemic immunity, the level of the
specific-anti-OVA IgG in serum after OVA immunization was
evaluated. The probiotic bacterium L. casei CRL 431 or the PFM
administration did not show increases in the anti-OVA IgG in serum
of wild type mice respect to immunized control. As regard to PFM, the
levels of specific IgG showed a decrease in TLR2-/- and MyD8-/-
C57BL/6 mice in comparison to the immunized control group and
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respect to wild type mice; however TLR4-/- showed similar values to
the immunized control. Whereas L. casei CRL 431 showed similar
values to immunized control in all cases. The probiotic bacterium
administration did not have a greater influence in the anti-OVA IgG
levels in the knockout mice. The data suggest that TLR would not be
involved in the anti-OVA response (Figure 7).
Figure 7: Anti-Ova Ig G from knockout mice serum. Dosage of
anti-Ova Ig G in serum (serum dilution 1:6000) 20 days post-
immunization from wild type C57BL/6, TLR2 -/- C57BL/6, TLR4-/-
C57BL/6, and MyD88-/- C57BL/6 mice, unimmunized (black bar),
immunized (grey bar), immunized and stimulated with L. casei
CRL 431 (dark-grey bar), and immunized and stimulated with PFM
(light-grey bar). a,b,c,dMeans values without a common letter differ
significantly (P<0.05).
Discussion
At the mucosal level, the innate immune response not only provides
the first line of defense against pathogenic microorganisms but also
provides the biological signals to evoke the adaptive immune response.
The key process is the recognition of microbial agents by Pattern-
Recognition Receptors (PRRs) which detect conserved microbial
ligands called Pathogen-Associated Molecular Patterns (PAMPs) [14].
This receptor system allows a clear and precise immune response.
Much attention has been focused on signal mediated by TLRs. By
detecting PAMPs, TLR engagement leads to adaptor molecule Myeloid
Differentiation Factor 88 (MyD88) recruitment and subsequent NF-κB
and MAPK-mediated transcriptional activation of a range of cytokines
and chemokines that orchestrate the early host resistance to infection
[15]. Moreover TLR signaling has been shown to have a protective role
in the intestine [16,17]. The constitutive activation of TLR signaling in
the intestinal epithelial cells is necessary to maintain the epithelial
homeostasis and regulate the composition of luminal microorganisms
by induction of the antimicrobial peptides and mucosal
immunoglobulin A secretion. Studies performed in MyD88 deficient
mice, showed more susceptibility to spontaneous intestinal infections
and defects in the antimicrobial peptides production by Paneth cells
[18].
Previous studies conducted in our laboratory showed that probiotic
bacteria induced increases in the TLRs expression in the immune cells
of lamina propria of the small intestine and in the Peyer´s patches,
which seemed to suggest the involvement of these receptors, in the
signaling pathways induced by probiotic microorganisms in the gut
[8,19]. In vitro studies demonstrated that two Lactobacillus strains, L.
rhamnosus GG and L. plantarum BFE 1685 increase the expression of
TLR2 in intestinal epithelial cells line HT-29 [20]. These studies led us
to determine whether probiotic bacteria or PFM administration are
able to send signals to increase the phagocytic activity of macrophages
distant from the gut such as peritoneal and spleen macrophages. We
observed that the best effect was obtained with the probiotic bacteria
administration (Figures 1A and 1C). We evaluated the importance of
the mentioned receptors, using TLR2 and TLR4 agonists and
antagonists and evaluated the immune adjuvant capacity of the
probiotic administration. Comparatively, for peritoneal macrophages,
the probiotics assayed or PFM administration had a similar effect to
that produced by TLR2 agonist, increasing the phagocytic activity of
these cells. In contrast, the addition of antagonist for two TLRs
studied, the phagocytic activity diminished even when the probiotic or
PFM were administered to mice. These results indicate that TLRs are,
not only involved in the phagocytic process of peritoneal
macrophages, but also they are a pathway used by probiotic
microorganisms to activate these cells. Similar results were obtained in
spleen macrophages (Figures 1A and 1C).
The intestinal epithelial cells are the first cell line of interaction with
probiotic microorganisms [8]. The activation of these cells leads to the
cytokine production, which are responsible for instructing the
underlying immune cells, mainly macrophages and dendritic cells.
When we analyzed the phagocytic activity of the Peyer´s patches
macrophages, less stimulation was shown even when the probiotic
bacteria and PFM were administered or for the agonist of TLRs
(Figure 1B). This low phagocytic activity may be due to the constant
exposition to the normal microbiota, causing that the cells to acquire a
tolerization state against microorganisms different to pathogenic
bacteria.
Different studies revealed that probiotic lactobacilli could induce
upregulation of IL-10 production and cell surface markers of
maturation and activation in DCs [21,22]. We analyzed by in vitro
assays the cytokine production by stimulated macrophages and the
importance of the TLR in this production. IL-10 was one of the
cytokine studied, considering that this cytokine is an important
regulator of the immune system. Distinct mechanisms regulate the
expression of this cytokine in the innate and acquired immune
systems, NF-κB activation is a major contributor to IL-10 production
in macrophages [23]. The probiotic administration induces high levels
of IL-10 in peritoneal macrophages, and TLR2 showed be the
preferred via for the IL-10 production, however the TLR4 agonist or
antagonist did not show any differences (Figure 2A). By previous
studies it was demonstrated that the L. casei CRL 431 and the PFM
were able to activate the NF-kB pathway [24], the results obtained for
IL-10 in presence of the TLR agonist reinforce the activation of this
pathway.
At the spleen, the macrophages behaviour was different than the
peritoneal macrophages. The levels of IL-10 were increased when the
cells were stimulated with both probiotics and PFM, but the levels
reached by IL-10, were lower than those obtained with peritoneal
macrophages. The role of antagonist or agonist for TLR2 or 4 was not
evident and maintained elevated the levels of this cytokine (Figure 2C).
In Peyer’s patches the IL-10 production was more regulated, the
probiotic administration did not induce high levels of this cytokine;
probably the complex microenvironment in which these cells coexist
could explain the different behaviour. The macrophages in this place
are in continuous interaction with different bacterial antigens that
enter with the diet and with the microbiota. It is known that these
intestinal macrophages are major producers of IL-10 and play pivotal
roles in the regulation of intestinal homeostasis and inflammation [25]
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and the IL-10 production was enhanced by colonization with
commensal microbiota [26,27]. It was also suggested that these cells do
not express TLR or expressed at very low amount [28] and have a
functional blockade in the downstream signalling of TLR [29]. This
evidence could explain the low levels of IL-10 obtained for the
intestinal macrophages even after probiotic bacteria stimulation,
suggesting that these microorganisms do not represent an aggression
signal for these cells (Figure 2B).
Other cytokine evaluated was the IL-6 production. This is
important in the early resolution phase of innate responses and in the
induction of acquired immunity [30,31]. Our results showed that the
probiotic or PFM administration induced elevated levels of IL-6
(Figures 2E and 2F), and this level being higher than the control when
the TLR2 or TLR4 agonists were added to the spleen and Peyer’s
patches macrophages culture, suggesting that these receptors are
involved in the signals that induce the secretion of this cytokine. In
fact, evidence from in vitro trials demonstrated that IL-6 production
was inhibited when viable or nonviable cultures of L. casei CRL 431
interacted with intestinal epithelial cells previously treated with anti-
mouse TLR2 antibody [32]. However, the IL-6 production by
peritoneal macrophages did not exceed the normal control values
(Figure 2D). Probably this last effect is a consequence of the high levels
of IL-10 produced by these macrophages, when they were stimulated
with the probiotic microorganisms, regulating the IL-6 production.
To evaluate if the activation of the macrophages induced by
probiotics mediated through the signals involving TLR2 and TLR4 is
also involved in other function of the macrophages, we analyzed by in
vitro and in vivo assays, the antimicrobial capacity of the
macrophages.
By in vitro assays, we observed that the antimicrobial activation was
strain specific. Probiotic bacteria L. casei CRL 431 was able to increase
the microbicidal activity of the peritoneal and spleen macrophages and
that this increase was TLR-dependent. The administration of PFM or
L. paracasei CNCM I-1518, showed a little increase in antimicrobial
activity (Figures 3A and 3B). These results could be explained
considering that also for the IL-6 production was different according
the different strains used. This cytokine are involved in the regulation
of the transcriptional factors and is crucial for the macrophages
bactericidal and tumoricidal activities [33].
The use of antagonist of TLR2 or 4 had a negative effect on the
microbicidal activity. This result is in concordance with the concept
that, the TLRs are required for the recognition of the pathogen and the
subsequent activation of the innate immune system, but it is important
to highlight that the probiotic strains assayed or the PFM
administration had an adjuvant effect on the microbicidal activity of
macrophages during the infection process even when, the TLRs are
blocked.
By in vivo studies, we performed an intraperitoneal infection with
Salmonella thyphimurium and the results confirm the effectiveness of
the macrophages, stimulated by the probiotic strains or the PFM, for
combating the pathogen, as it was evidenced by a significant
diminution in the number of counting of bacterial cells in the spleen
and liver during the first 30 hr post-infection (Figures 4A and 4B).
To validate the previous studies, where we demonstrated the
implication of the signal induced by probiotic through TLR2 and
TLR4 in the phagocytic activity of macrophages, we performed the
same assay using TLR2-/-, TLR4-/- and MyD88-/- mice. Even though
the TLRs are not categorized as phagocytic receptors, our results
showed that peritoneal macrophages in TLR2 and TLR4 knockout
mice, we showed that the phagocytic activity was significantly
diminished in comparison with the wild type mice and that the
administration of a probiotic bacteria or PFM was not able to increase
the activity of peritoneal macrophages in knockout mice (Figure 5).
Furthermore MyD88, turned out to be indispensable for this process.
In addition increased IL-10 production was obtained when
peritoneal macrophages were stimulated with a concentration of 108
cells/ml of the probiotic L. casei CRL 431. Deficiency of TLR4 and 2,
produced a significant decrease in the IL-10 production; however the
production of this cytokine was almost completely abolished in
MyD88-deficient animals (Figure 6). There is a report that shows
MyD88 has an important role in the IL-10 induction during Porcine
Reproductive And Respiratory Syndrome Virus (PRRSV) infection
[34].
These results agree with those obtained in knockout mice, where
the adaptor molecule MyD88, demonstrated to have an unquestioned
role in the IL-10 production by peritoneal macrophages stimulated
with the probiotic bacterium L. casei CRL 431.
These results led us to infer that TLRs play an important role in the
phagocytic process and in the cytokine production as IL-10, but they
did not play a key effect on the systemic immunity, due to the level of
specific anti-OVA IgG did not diminished drastically in TLR knockout
mice (Figure 7).
The probiotic strains assayed or the Probiotic Fermented Milk that
contain these microorganisms, were able to modulate the
macrophages activity through the TLR2 and TLR4 pathway. We
demonstrated the influence of these receptors, after oral stimulation
with probiotic strains or a PFM in the phagocytic and microbicidal
activity of macrophages. We determine that the probiotics through the
TLR2 and TLR4 mediate macrophages stimulation to induce an innate
immune response, and to send signals to enhance the adaptive
immune response. Even when each strain had different behaviour and
induces different cytokine profile, the beneficial effect on the
macrophages activation was demonstrated.
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